Dominick J. Demsak Lpc, Llc Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 2 Fawn Lake Rd, Stockholm, NJ 07460 Phone: 973-919-3795 |
Cam Psychotherapy Services Llc Counselor - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 4 Beaver Trl, Stockholm, NJ 07460 Phone: 201-500-5997 |
Vanessa Ventricelli Counseling Lcsw Llc Clinic - Mental Health Medicare: Not Enrolled in Medicare Practice Location: 26 Stonehedge Dr, Stockholm, NJ 07460 Phone: 908-791-5705 |
Capitol Care, Inc. Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 8 Silver Lake Rd, Stockholm, NJ 07460 Phone: 973-426-1440 |
News Archive
Obtaining and documenting informed patient consent prior to surgery is of vital importance, but both the process and documentation of consent can be inadequate.
Neisseria meningitidis, the meningococcus, is a bacterium that can cause diseases with high fatality rates, and there has therefore been considerable concern that, like other bacteria, it might become resistant to antibiotics. But now a study from örebro University and örebro University Hospital in Sweden shows that there has not been any increase in resistant meningococci in Sweden over the last 15 years. According to researcher Sara Thulin Hedberg, the reason for this may be that it is not especially advantageous for bacteria to develop resistance.
Now, researchers at the University of Silesia in Katowice and the Poznan University of Medical Sciences in Poland recommend measures to prevent future zoonotic outbreaks. They emphasized the importance of viral surveillance and research on new viral strains as primary strategies to combat these infections.
Sotera Wireless, Inc. today announced its acquisition of Reflectance Medical Inc., a privately held company that has developed first-of-its kind technology aimed at detecting potentially life threatening conditions in critically ill patients, including those who have suffered trauma injuries.
Neurological and infectious disease experts at Rush University Medical Center are testing a new drug therapy for the treatment of individuals with West Nile fever or suspected central nervous system infection due to the West Nile virus. Rush is the only site in the Midwest enrolling patients into the $50 million dollar, NIH-funded, Phase II clinical trial called PARADIGM.
› Verified 9 days ago